Search This Blog

Monday, May 11, 2015

Lilly and BioNTech Announce Research Collaboration on Novel Cancer Immunotherapies (NYSE:LLY)

INDIANAPOLIS and MAINZ, Germany, May 11, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and BioNTech AG today announced they have entered into a research collaboration to discover novel cancer immunotherapies. The companies will seek to use the power of the body's own immune system to attack cancer cells and create possible new treatment options for cancer patients.



Lilly and BioNTech Announce Research Collaboration on Novel Cancer Immunotherapies (NYSE:LLY)
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)